College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, Zhejiang, China.
Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, 02881, USA.
Curr Microbiol. 2020 Aug;77(8):1412-1418. doi: 10.1007/s00284-020-01888-6. Epub 2020 Mar 18.
Ectoine is widely produced by various bacteria as a natural cell protectant against environment stress, e.g., osmotic and temperature stress. Its protective properties therefore exhibit high commercial value, especially in agriculture, medicine, cosmetics, and biotechnology. Here, we successfully constructed an engineered Escherichia coli for the heterologous production of ectoine. Firstly, the ectABC genes from Halomonas elongata were introduced into E. coli MG1655 to produce ectoine without high osmolarity. Subsequently, lysA gene was deleted to weaken the competitive L-lysine biosynthesis pathway and ectoine bioconversion was further optimized, leading to an increase of ectoine titer by 16.85-fold. Finally, at the low cell density of 5 OD/mL in Erlenmeyer flask, the concentration of extracellular ectoine was increased to 3.05 mg/mL. At the high cell density of 15 OD/mL, 12.7 g/L of ectoine was achieved in 24 h and the overall yield is 1.27 g/g glycerol and sodium aspartate. Our study herein provides a feasible and valuable biosynthesis pathway of ectoine with a potential for large-scale industrial production using simple and cheap feedstocks.
章鱼胺广泛存在于各种细菌中,是一种天然的细胞保护剂,可以抵抗环境压力,如渗透压和温度压力。因此,其保护性能具有很高的商业价值,特别是在农业、医学、化妆品和生物技术领域。在这里,我们成功构建了一株用于章鱼胺异源生产的工程大肠杆菌。首先,我们将来自盐单胞菌的 ectABC 基因导入大肠杆菌 MG1655 中,在没有高渗透压的情况下生产章鱼胺。随后,我们敲除了 lysA 基因以削弱竞争性 L-赖氨酸生物合成途径,并进一步优化了章鱼胺的生物转化,使章鱼胺的产量提高了 16.85 倍。最后,在摇瓶中低细胞密度为 5 OD/mL 的条件下,将细胞外章鱼胺的浓度提高到 3.05 mg/mL。在高细胞密度为 15 OD/mL 的条件下,24 h 内可获得 12.7 g/L 的章鱼胺,甘油和天冬氨酸钠的总产率为 1.27 g/g。本研究提供了一种可行且有价值的章鱼胺生物合成途径,具有使用简单廉价的原料进行大规模工业生产的潜力。